These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19414484)

  • 21. Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population.
    Atasilp C; Kanjanapipak J; Vichayaprasertkul J; Jinda P; Tiyasirichokchai R; Srisawasdi P; Prempunpong C; Chamnanphon M; Puangpetch A; Vanwong N; Klongthalay S; Jantararoungtong T; Sukasem C
    BMC Pediatr; 2022 May; 22(1):243. PubMed ID: 35501760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic influences on serum bilirubin in American Indians: The Strong Heart Family Study.
    Melton PE; Haack K; Göring HH; Laston S; Umans JG; Lee ET; Fabsitz RR; Devereux RB; Best LG; Maccluer JW; Almasy L; Cole SA
    Am J Hum Biol; 2011; 23(1):118-25. PubMed ID: 21080475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UGT1A1 is a major locus influencing bilirubin levels in African Americans.
    Chen G; Ramos E; Adeyemo A; Shriner D; Zhou J; Doumatey AP; Huang H; Erdos MR; Gerry NP; Herbert A; Bentley AR; Xu H; Charles BA; Christman MF; Rotimi CN
    Eur J Hum Genet; 2012 Apr; 20(4):463-8. PubMed ID: 22085899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Factors and Delayed TSB Monitoring and Treatment as Risk Factors Associated with Severe Hyperbilirubinemia in Term Neonates Admitted for Phototherapy.
    Boo NY; Sin S; Chee SC; Mohamed M; Ahluwalia AK; Ling MM; Ong HK
    J Trop Pediatr; 2020 Dec; 66(6):569-582. PubMed ID: 32577754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.
    Varenhorst C; Eriksson N; Johansson Å; Barratt BJ; Hagström E; Åkerblom A; Syvänen AC; Becker RC; James SK; Katus HA; Husted S; Steg PG; Siegbahn A; Voora D; Teng R; Storey RF; Wallentin L;
    Eur Heart J; 2015 Aug; 36(29):1901-12. PubMed ID: 25935875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations.
    Lampe JW; Bigler J; Horner NK; Potter JD
    Pharmacogenetics; 1999 Jun; 9(3):341-9. PubMed ID: 10471066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.
    Treviño LR; Shimasaki N; Yang W; Panetta JC; Cheng C; Pei D; Chan D; Sparreboom A; Giacomini KM; Pui CH; Evans WE; Relling MV
    J Clin Oncol; 2009 Dec; 27(35):5972-8. PubMed ID: 19901119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex multifactorial nature of significant hyperbilirubinemia in neonates.
    Watchko JF; Lin Z; Clark RH; Kelleher AS; Walker MW; Spitzer AR;
    Pediatrics; 2009 Nov; 124(5):e868-77. PubMed ID: 19858149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of genetic variants of bilirubin metabolism on the degree of hyperbilirubinemia in African-American newborns.
    Schutzman DL; Baudhuin LM; Gatien E; Ajayi S; Wong RJ
    J Perinatol; 2017 Apr; 37(4):432-435. PubMed ID: 27977017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple Genetic Modifiers of Bilirubin Metabolism Involvement in Significant Neonatal Hyperbilirubinemia in Patients of Chinese Descent.
    Yang H; Wang Q; Zheng L; Lin M; Zheng XB; Lin F; Yang LY
    PLoS One; 2015; 10(7):e0132034. PubMed ID: 26146841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide association studies go green: novel and cost-effective opportunities for identifying genetic associations.
    Vachon CM
    Mayo Clin Proc; 2011 Jul; 86(7):597-9. PubMed ID: 21719615
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.
    Cox AJ; Ng MC; Xu J; Langefeld CD; Koch KL; Dawson PA; Carr JJ; Freedman BI; Hsu FC; Bowden DW
    Atherosclerosis; 2013 Jul; 229(1):155-60. PubMed ID: 23642732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation.
    Zhang W; He YJ; Gan Z; Fan L; Li Q; Wang A; Liu ZQ; Deng S; Huang YF; Xu LY; Zhou HH
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1240-4. PubMed ID: 17973861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between heterozygosity for UGT1A1*6, UGT1A1*28, and variation in the serum total-bilirubin level in healthy young Japanese adults.
    Moriya H; Saito K; Helsby N; Sugino S; Yamakage M; Takasaki M; Kato H; Kurosawa N
    Genet Test Mol Biomarkers; 2013 Jun; 17(6):464-9. PubMed ID: 23537215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UDP-Glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women.
    Hong AL; Huo D; Kim HJ; Niu Q; Fackenthal DL; Cummings SA; John EM; West DW; Whittemore AS; Das S; Olopade OI
    Drug Metab Dispos; 2007 Aug; 35(8):1254-61. PubMed ID: 17478602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients.
    Onoue M; Terada T; Kobayashi M; Katsura T; Matsumoto S; Yanagihara K; Nishimura T; Kanai M; Teramukai S; Shimizu A; Fukushima M; Inui K
    Int J Clin Oncol; 2009 Apr; 14(2):136-42. PubMed ID: 19390945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence of Gilbert syndrome and its genetic determinants in Chile].
    Méndez L; Lagoa M; Quiroga T; Margozzini P; Azócar L; Molina HR; Vera A; Villarroel L; Arrese M; Hampe J; Buch S; Miquel JF
    Rev Med Chil; 2013 Oct; 141(10):1266-74. PubMed ID: 24522354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms.
    Sato H; Uchida T; Toyota K; Nakamura T; Tamiya G; Kanno M; Hashimoto T; Watanabe M; Aoki K; Hayasaka K
    J Hum Genet; 2015 Jan; 60(1):35-40. PubMed ID: 25391605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association?
    Alencastro de Azevedo L; Reverbel da Silveira T; Carvalho CG; Martins de Castro S; Giugliani R; Matte U
    Pediatr Res; 2012 Aug; 72(2):169-73. PubMed ID: 22580719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of the UGT1A1*60 allele on bilirubin serum concentrations.
    Pasternak AL; Crews KR; Caudle KE; Smith C; Pei D; Cheng C; Broeckel U; Gaur AH; Hankins J; Relling MV; Haidar CE
    Pharmacogenomics; 2017 Jan; 18(1):5-16. PubMed ID: 27967321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.